Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-018506
Filing Date
2018-06-27
Accepted
2018-06-27 20:38:46
Documents
1
Period of Report
2018-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5991
  Complete submission text file 0000899243-18-018506.txt   7390
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 18923022